These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1752541)

  • 21. High prevalence of anti-cardiolipin antibody, C1q-, C3d-, and mRF-IgG immune complexes, and anti-nuclear antibody in hemophiliacs irrespective of infection with human immunodeficiency virus type 1.
    Matsuda J; Gohchi K; Hama H; Tsukamoto M; Saitoh N; Kinoshita T
    J Acquir Immune Defic Syndr (1988); 1993 Oct; 6(10):1120-4. PubMed ID: 8410668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents. Hemophilia Growth and Development Study Group.
    Jason J; Murphy J; Sleeper LA; Donfield SM; Warrier I; Arkin S; Evatt B; Gomperts ED
    Am J Hematol; 1994 May; 46(1):29-35. PubMed ID: 8184874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Virus in hemophilia: current status and future perspectives].
    Aguilar C; Félix Lucía J
    Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
    [No Abstract]   [Full Text] [Related]  

  • 24. Spectrum of HIV infection and AIDS in a cohort of Italian hemophiliacs.
    Sorice F; Ghirardini A; Martino P; Pasqualetti D; Annino L; Micozzi A; Cirelli A; Tamburrini E; Isacchi G; Buttò S
    Haematologica; 1989; 74(2):149-54. PubMed ID: 2568323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic abnormalities in patients with chronic delta infection.
    Castello G; Ciampi R; Leonardi E; Abrescia N; Ronga D; D'Alessio V
    Boll Ist Sieroter Milan; 1988; 67(5-6):337-44. PubMed ID: 2908737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemophilia care in Zimbabwe.
    Adewuyi JO; Coutts AM; Levy L; Lloyd SE
    Cent Afr J Med; 1996 May; 42(5):153-6. PubMed ID: 8771937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of HIV on health care delivery in haemophilia.
    Rickard KA
    Prog Clin Biol Res; 1990; 324():101-11. PubMed ID: 2408049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study.
    Eyster ME; Sherman KE; Goedert JJ; Katsoulidou A; Hatzakis A
    J Infect Dis; 1999 May; 179(5):1062-9. PubMed ID: 10191205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eluding transfusion-transmitted HIV infection: report of two cases.
    Chuansumrit A; Hathirat P; Iamsilp W; Chiewsilp P; Isarangkura P
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S99-101. PubMed ID: 9347654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contaminated blood case nears end.
    Maddox J
    Nature; 1993 Jun; 363(6429):491. PubMed ID: 8505974
    [No Abstract]   [Full Text] [Related]  

  • 31. Quebec challenges blood inquiry.
    Spurgeon D
    Nature; 1996 Apr; 380(6575):572. PubMed ID: 8602251
    [No Abstract]   [Full Text] [Related]  

  • 32. Humoral immune response in patients with hemophilia.
    Matheson DS; Green BJ; Fritzler MJ; Poon MC; Bowen TJ; Hoar DI
    Clin Immunol Immunopathol; 1987 Jul; 44(1):41-50. PubMed ID: 3109792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV compensation package under offer.
    Barker S
    Nature; 1995 Oct; 377(6549):467. PubMed ID: 7566130
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of high-risk HIV-1 seronegative hemophiliacs.
    Salkowitz JR; Purvis SF; Meyerson H; Zimmerman P; O'Brien TR; Aledort L; Eyster ME; Hilgartner M; Kessler C; Konkle BA; White GC; Goedert JJ; Lederman MM
    Clin Immunol; 2001 Feb; 98(2):200-11. PubMed ID: 11161976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of HIV infection in the hemophilic population].
    de Tezanos Pinto M
    Medicina (B Aires); 1998; 58 Suppl 1():45-8. PubMed ID: 9674247
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology of HIV infection in multitransfused hemophilic patients in France. French Study Group in Hemophilia.
    Sultan Y
    Nouv Rev Fr Hematol (1978); 1987; 29(4):211-4. PubMed ID: 3697063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
    Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
    Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
    Jackson JB; Kataaha P; Hom DL; Mmiro F; Guay L; Ndugwa C; Marum L; Piwowar E; Brewer K; Toedter G
    AIDS; 1993 Nov; 7(11):1475-9. PubMed ID: 8280414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion.
    Müller C; Kukel S; Bauer R
    Immunology; 1993 Jun; 79(2):248-54. PubMed ID: 8102120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
    Sabin CA; Devereux HL; Clewley G; Emery VC; Phillips AN; Loveday C; Lee CA; Griffiths PD
    J Infect Dis; 2000 May; 181(5):1800-3. PubMed ID: 10823788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.